[go: up one dir, main page]

TN2013000507A1 - Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer. - Google Patents

Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer.

Info

Publication number
TN2013000507A1
TN2013000507A1 TNP2013000507A TN2013000507A TN2013000507A1 TN 2013000507 A1 TN2013000507 A1 TN 2013000507A1 TN P2013000507 A TNP2013000507 A TN P2013000507A TN 2013000507 A TN2013000507 A TN 2013000507A TN 2013000507 A1 TN2013000507 A1 TN 2013000507A1
Authority
TN
Tunisia
Prior art keywords
cancer
treatment
effector functions
cxcr4 antibody
cxcr4
Prior art date
Application number
TNP2013000507A
Other languages
French (fr)
Inventor
Christine Klinguer-Hamour
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/061893 external-priority patent/WO2012175576A1/en
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of TN2013000507A1 publication Critical patent/TN2013000507A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present application relates to a method of treating cancer by administering an anti-CXCR4 monoclonal antibody capable of inducing effector function (s).
TNP2013000507A 2011-06-20 2013-12-05 Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer. TN2013000507A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161499004P 2011-06-20 2011-06-20
PCT/EP2012/061893 WO2012175576A1 (en) 2011-06-20 2012-06-20 Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer.

Publications (1)

Publication Number Publication Date
TN2013000507A1 true TN2013000507A1 (en) 2015-03-30

Family

ID=54359616

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000507A TN2013000507A1 (en) 2011-06-20 2013-12-05 Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer.

Country Status (1)

Country Link
TN (1) TN2013000507A1 (en)

Similar Documents

Publication Publication Date Title
AU2012335543A8 (en) HER3 antibodies and uses thereof
MX2021002728A (en) Combination of anti-lag-3 antibodies and anti-pd-1 antibodies to treat tumors.
CA3019531A1 (en) Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
SG194701A1 (en) Anti-cd40 antibodies and methods of use
EA201491011A1 (en) METHODS OF TREATMENT BY MEANS OF THE GAMMA INTERFERON INHIBITOR
TN2015000050A1 (en) Methods of treating a tauopathy
MX357965B (en) Pharmaceutical composition for treatment and/or prevention of gall bladder cancer.
NZ707086A (en) Anti-cd40 antibodies and methods of use
MY196418A (en) Therapeutically Active Compounds and Their Methods of use
MX347020B (en) Antibody against the csf-1r.
EA201200998A1 (en) METHODS OF TREATING CANCER CANCER
MX2015011772A (en) Anti-hepcidin antibodies and uses thereof.
NZ631197A (en) Anti sez6 antibodies and methods of use
PH12014500904B1 (en) Antibody formulations and methods
UA106890C2 (en) LibreOfficeantibody to CDCP1
EA201591786A1 (en) GLA MONOTHERAPY FOR APPLICATION IN CANCER TREATMENT
BR112013032456A2 (en) anti-cxcr4 antibody with effector functions and its use for cancer treatment
GEP201706612B (en) Methods for the treatment of breast cancer
NZ611785A (en) Anti-notch1 antibodies
MX2019015604A (en) Methods of treating a tauopathy.
EA202091676A1 (en) METHOD FOR TREATMENT OF BONE MASS LOSS OF ALVEOLAR PROCESSING BY APPLICATION OF ANTIBODIES TO SCLEROSTIN
NZ603191A (en) Methods for the treatment of il-1b related conditions
PH12014501543A1 (en) Combination therapy for the treatment of ovarian cancer
MX343968B (en) Proteasome inhibitor delanzomib for use in the treatment of lupus.
MX2013009529A (en) Treatment of fistulizing crohn's disease.